Given that Ras/Raf is upstream of the MAPK pathway that results in ERK phosphorylation, we hypothesized that RDM1 modulated HCC progression by suppressing KRAS‐mediated MAPK/ERK signaling. The gene discussed is KRAS; the disease is hepatocellular carcinoma.